Figure 5.

Relative transcript abundance for ESR1, PGR, and ERBB2 in the Basal-like subtype. There was no difference (pā€‰>ā€‰0.05) in (A) ESR1, (B) PGR, or (C) ERBB2 expression by qPCR in Basal-like tumors, regardless of being called triple-negative or non-triple negative by IHC/CISH.

Bastien et al. BMC Medical Genomics 2012 5:44   doi:10.1186/1755-8794-5-44
Download authors' original image